| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |